미 연방거래위원회, FTC Secures Major Settle
미 연방거래위원회가(Federal Trade Commission) 2026-07-14 공개한 'FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman' 발표를 바탕으로, 확인 가능한 사실을 중심으로 정리했습니다.
어떤 발표인가
The Federal Trade Commission secured a settlement agreement with one of the nation’s largest pharmacy benefit managers (PBMs) and its affiliated entities, marking yet another important victory in the Commission’s fight to lower healthcare costs for Americans.
발표에서 확인되는 내용
- Caremark Rx LLC and Zinc Health Services LLC (collectively Caremark) have agreed to a settlement agreement that requires the PBM to adopt changes to its business practices to drive down patients’ out-of-pocket costs, increase transparency and ensure community pharmacies are treated fairly.
- “The FTC under President Trump won’t stand for anticompetitive behavior that drives up prices for American consumers,” said Chairman Andrew N.
- “The settlement with Caremark brings billions in real savings to consumers feeling the pinch from excessive prescription drug prices.
- And the settlement bars Caremark from interfering with hub pharmacies, which can help identify the lowest out-of-pocket option for patients and improve patient access to prescriptions.
- Today’s action builds on previous wins for President Trump’s healthcare agenda, including innovations like TrumpRx to make prescription drug prices more transparent and affordable for everyone.” The FTC’s settlement with Caremark locks in place up to $8.5 billion in consumer savings over the next 10 years and unlocks up to $4.5 billion in additional savings for patients over the same 10-year period from point-of-sale rebates.
숫자와 고유명사
- The Federal Trade Commission secured a settlement agreement with one of the nation’s largest pharmacy benefit managers (PBMs) and its affiliated entities, marking yet another important victory in the Commission’s fight to lower healthcare costs for Americans
- Caremark Rx LLC and Zinc Health Services LLC (collectively Caremark) have agreed to a settlement agreement that requires the PBM to adopt changes to its business practices to drive down patients’ out-of-pocket costs, increase transparency and ensure community
- “The FTC under President Trump won’t stand for anticompetitive behavior that drives up prices for American consumers,” said Chairman Andrew N
- “The settlement with Caremark brings billions in real savings to consumers feeling the pinch from excessive prescription drug prices
- And the settlement bars Caremark from interfering with hub pharmacies, which can help identify the lowest out-of-pocket option for patients and improve patient access to prescriptions
한눈에 보는 원문 기준
| 항목 | 내용 |
|---|---|
| 발표 기관 | 미 연방거래위원회 (Federal Trade Commission) |
| 발표일 | 2026-07-14 |
| 원문 제목 | FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman |
| 분류 기준 | 정책 / 정책 법 집행 규제 제도 예산 기관 발표 |
| 원문 | Federal Trade Commission release |
한국 독자가 볼 부분
소비자 보호나 개인정보, 결제 관행과 관련된 발표라면 국내 서비스 이용자도 유사한 약관, 환불, 데이터 활용 방식을 비교해 볼 수 있습니다. 특히 플랫폼 기업이나 해외 서비스를 쓰는 경우에는 미국 규제기관이 문제 삼은 행위가 무엇인지 확인하는 것이 도움이 됩니다.
원문 확인
🎁 [브리핑웨이브 추천] 일상 속 가치를 더하는 실시간 핫딜공공 소식과 함께 일상에서 만족도가 높은 검증된 가성비 상품을 엄선했습니다.
자주 묻는 질문
- 미국정부 지원·적용 대상은 어디서 확인하나요?
- 본문의 소득·지역·연령·사업자 조건을 먼저 확인한 뒤, 담당 기관의 공식 공고에서 제외 대상과 중복 지원 제한을 확인하세요.
- 신청처와 마감일은 어떻게 확인하나요?
- 아래 공식 출처 버튼에서 접수 시작·마감 시각, 온라인·방문 신청 여부와 필수 서류를 확인하세요.
공식 정보는 어디에서 확인하나요?
편집 기준
공식 발표를 그대로 옮기기보다 독자가 확인해야 할 대상, 시점, 절차, 후속 확인 경로를 중심으로 다시 정리했습니다.
광고